You can always press Enter⏎ to continue
CARE™ at ASH 2020 Evaluation Form
In an ongoing effort to improve the quality of our meetings, we request your valuable feedback.
10
Questions
START
1
1. I am a:
Physician
Trainee
Nurse/aHCP
Other
Previous
Next
Submit
Press
Enter
2
2. How likely is it that you will make a change to your clinical practice and/or work as a result of attending this program?
1
2
3
4
5
Very Unlikely
Very Likely
Previous
Next
Submit
Press
Enter
3
3. How likely are you to recommend this conference to a colleague?
1
2
3
4
5
Very Unlikely
Very Likely
Previous
Next
Submit
Press
Enter
4
4. How did you hear about the event? Please select all that apply.
Email invitation
From a colleague
Attended previously
CARE™ Website
Twitter
Other
Previous
Next
Submit
Press
Enter
5
5. Please rate the following presentations:
1 = Not Valuable, 5 = Very Valuable
1
2
3
4
5
Plasma Cell Dyscrasias – Dr. Chris Venner (Cross Cancer Institute)
Row 0, Column 0
Row 0, Column 1
Row 0, Column 2
Row 0, Column 3
Row 0, Column 4
Chronic Lymphocytic Leukemia – Dr. Graeme Fraser (Juravinski Cancer Centre)
Row 1, Column 0
Row 1, Column 1
Row 1, Column 2
Row 1, Column 3
Row 1, Column 4
Lymphoma – Dr. Anca Prica (Princess Margaret Cancer Centre)
Row 2, Column 0
Row 2, Column 1
Row 2, Column 2
Row 2, Column 3
Row 2, Column 4
Immunotherapy – Dr. Kevin Hay (BC Cancer)
Row 3, Column 0
Row 3, Column 1
Row 3, Column 2
Row 3, Column 3
Row 3, Column 4
Thrombosis – Dr. Wendy Lim (McMaster University)
Row 4, Column 0
Row 4, Column 1
Row 4, Column 2
Row 4, Column 3
Row 4, Column 4
Leukemia – Dr. Julie Stakiw (College of Medicine)
Row 5, Column 0
Row 5, Column 1
Row 5, Column 2
Row 5, Column 3
Row 5, Column 4
Benign Disorders – Dr. Denis Soulières (CHUM)
Row 6, Column 0
Row 6, Column 1
Row 6, Column 2
Row 6, Column 3
Row 6, Column 4
Plasma Cell Dyscrasias – Dr. Chris Venner (Cross Cancer Institute)
Chronic Lymphocytic Leukemia – Dr. Graeme Fraser (Juravinski Cancer Centre)
Lymphoma – Dr. Anca Prica (Princess Margaret Cancer Centre)
Immunotherapy – Dr. Kevin Hay (BC Cancer)
Thrombosis – Dr. Wendy Lim (McMaster University)
Leukemia – Dr. Julie Stakiw (College of Medicine)
Benign Disorders – Dr. Denis Soulières (CHUM)
1
Row 0, Column 0
2
Row 0, Column 1
3
Row 0, Column 2
4
Row 0, Column 3
5
Row 0, Column 4
1
Row 1, Column 0
2
Row 1, Column 1
3
Row 1, Column 2
4
Row 1, Column 3
5
Row 1, Column 4
1
Row 2, Column 0
2
Row 2, Column 1
3
Row 2, Column 2
4
Row 2, Column 3
5
Row 2, Column 4
1
Row 3, Column 0
2
Row 3, Column 1
3
Row 3, Column 2
4
Row 3, Column 3
5
Row 3, Column 4
1
Row 4, Column 0
2
Row 4, Column 1
3
Row 4, Column 2
4
Row 4, Column 3
5
Row 4, Column 4
1
Row 5, Column 0
2
Row 5, Column 1
3
Row 5, Column 2
4
Row 5, Column 3
5
Row 5, Column 4
1
Row 6, Column 0
2
Row 6, Column 1
3
Row 6, Column 2
4
Row 6, Column 3
5
Row 6, Column 4
1
of 7
Previous
Next
Submit
Press
Enter
6
6. Please rate the following:
Strongly Disagree
Disagree
Neutral
Agree
Strongly Agree
Registration and conference information was easy to obtain
Row 0, Column 0
Row 0, Column 1
Row 0, Column 2
Row 0, Column 3
Row 0, Column 4
The conference provided a valuable opportunity to share information and network
Row 1, Column 0
Row 1, Column 1
Row 1, Column 2
Row 1, Column 3
Row 1, Column 4
The conference timing and length were acceptable
Row 2, Column 0
Row 2, Column 1
Row 2, Column 2
Row 2, Column 3
Row 2, Column 4
Overall the conference was well organized
Row 3, Column 0
Row 3, Column 1
Row 3, Column 2
Row 3, Column 3
Row 3, Column 4
Registration and conference information was easy to obtain
The conference provided a valuable opportunity to share information and network
The conference timing and length were acceptable
Overall the conference was well organized
Strongly Disagree
Row 0, Column 0
Disagree
Row 0, Column 1
Neutral
Row 0, Column 2
Agree
Row 0, Column 3
Strongly Agree
Row 0, Column 4
Strongly Disagree
Row 1, Column 0
Disagree
Row 1, Column 1
Neutral
Row 1, Column 2
Agree
Row 1, Column 3
Strongly Agree
Row 1, Column 4
Strongly Disagree
Row 2, Column 0
Disagree
Row 2, Column 1
Neutral
Row 2, Column 2
Agree
Row 2, Column 3
Strongly Agree
Row 2, Column 4
Strongly Disagree
Row 3, Column 0
Disagree
Row 3, Column 1
Neutral
Row 3, Column 2
Agree
Row 3, Column 3
Strongly Agree
Row 3, Column 4
1
of 4
Previous
Next
Submit
Press
Enter
7
7. Did you find the virtual conference to be more accessible to you than the live conference?
Yes
No
Previous
Next
Submit
Press
Enter
8
8. How did you find the CARE™ at ASH virtual experience versus the live conference experience?
Previous
Next
Submit
Press
Enter
9
9. Of the material covered, which topic/discussion is of most relevance to your clinical practice?
Huge
Large
Normal
Small
Ok
quote
Created with Sketch.
Ok
Previous
Next
Submit
Press
Enter
10
10. Looking at what was covered, give one example of how you will apply your learning from CARE™ at ASH 2020 today in your practice.
Huge
Large
Normal
Small
Ok
quote
Created with Sketch.
Ok
Previous
Next
Submit
Press
Enter
Should be Empty:
Question Label
1
of
10
See All
Go Back
Submit
